Tapinarof
Tapinarof (Benvitimod) is a topical small molecule aryl hydrocarbon receptor (AhR) agonist developed for psoriasis treatment. It modulates immune and keratinocyte pathways, showing efficacy in both in vitro assays and clinical trials for plaque psoriasis.
Product Specifications
CAS Number
79338-84-4
Product Name Alternative
ArylHydrocarbonReceptor, Aryl Hydrocarbon Receptor, AhR, Benvitimod, Inhibitor, inhibit, GSK 2894512, GSK2894512, GSK-2894512, WBI 1001, WBI1001, WBI-1001, Tapinarof
Field of Research
Immunology & Inflammation, Metabolism Research
Purity
99.64% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (7.86 mM) ; DMSO:55 mg/mL (216.26 mM)
Smiles
CC (C) c1c (O) cc (\C=C\c2ccccc2) cc1O
Molecular Formula
C17H18O2
Molecular Weight
254.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS634849-01 25 mg
Ubiquitin, Bovine (FLJ25987, MGC8385, Polyubiquitin B, RPS27A, UBA52, UBA80, UBC, UBCEP1, UBCEP2, Ubiquitin B, UBB)
Sign In for Pricing
View Details MBS634849-02 5x 25 mg
Ubiquitin, Bovine (FLJ25987, MGC8385, Polyubiquitin B, RPS27A, UBA52, UBA80, UBC, UBCEP1, UBCEP2, Ubiquitin B, UBB)
Sign In for Pricing
View Details